ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Capricor Therapeutics (CAPR) Technical (Analysis) Reports Capricor Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Capricor Therapeutics (CAPR)

Technical Analysis Report for NASDAQ stock CAPR Capricor Therapeutics. Dated: 27 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock CAPR Capricor Therapeutics then click here. or read Experts views on Capricor Therapeutics or Forecast & share price targets of Capricor Therapeutics

Capricor Therapeutics Opened at 5.88 and Closed at: 6.10, which is 5.74% of previous session's close. It moved within a range of 5.67 and 6.31
The session was a Bullish session with an average volume of 2372015, which is 56.87% of previous session's volumes.

  • Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
  • Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.

A Dead cross was found 9 days back on mid term averages

Support for tomorrow is 5.89 and resistance for tomorrow is 6.53
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 5.74, 5.39 resistance for tomorrow's hourly charts is 6.38, 6.67

10 Day SMA for Capricor Therapeutics (CAPR) is 6.36 and stock is trading below these levels. This is not a good sign for its short term trend

20 Day SMA for Capricor Therapeutics (CAPR) is 7.24 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Capricor Therapeutics (CAPR) is 8.11 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 12.9 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Capricor Therapeutics is 20.93 and stock is trading below these levels. This is not a good sign for its long term trend

20 DMA of Capricor Therapeutics is at 7.24 and 200 DMA is at 20.93, while 50 DMA and 100 DMA are at 8.11 and 12.9 respectively

Capricor Therapeutics (CAPR) moving average of 20 SMA is at 7.24 and 20 EMA is at 6.98

Capricor Therapeutics (CAPR) moving average of 50 SMA is at 8.11 and 50 EMA is at 8.67

Capricor Therapeutics (CAPR) moving average of 100 SMA is at 12.9 and 100 EMA is at 12.32

Capricor Therapeutics (CAPR) moving average of 200 SMA is at 20.93 and 200 EMA is at 15.42

Amgen Inc has performed better than Capricor Therapeutics in short term. You could have earned much better returns by investing in Amgen Inc, about 41.86% more returns!

Alphatec Holdings has performed better than Capricor Therapeutics in short term. You could have earned much better returns by investing in Alphatec Holdings, about 40.92% more returns!

Biolinerx has performed better than Capricor Therapeutics in short term. You could have earned much better returns by investing in Biolinerx, about 21.97% more returns!

Collplant Holdings has performed better than Capricor Therapeutics in short term. You could have earned much better returns by investing in Collplant Holdings, about 38.76% more returns!

Cellectar Biosciences has performed better than Capricor Therapeutics in short term. You could have earned much better returns by investing in Cellectar Biosciences, about 1.35% more returns!

Cytokinetics Incorporated has performed better than Capricor Therapeutics in short term. You could have earned much better returns by investing in Cytokinetics Incorporated, about 28.93% more returns!

Denali Therapeutics has performed better than Capricor Therapeutics in short term. You could have earned much better returns by investing in Denali Therapeutics, about 28.58% more returns!

Incyte Corporation has performed better than Capricor Therapeutics in short term. You could have earned much better returns by investing in Incyte Corporation, about 31.68% more returns!

Inmune Bio has performed better than Capricor Therapeutics in short term. You could have earned much better returns by investing in Inmune Bio, about 13.54% more returns!

Moleculin Biotech has performed better than Capricor Therapeutics in short term. You could have earned much better returns by investing in Moleculin Biotech, about 1789.59% more returns!

Oncolytics Biotech has performed better than Capricor Therapeutics in short term. You could have earned much better returns by investing in Oncolytics Biotech, about 5.74% more returns!

Protagonist Therapeutics has performed better than Capricor Therapeutics in short term. You could have earned much better returns by investing in Protagonist Therapeutics, about 35.75% more returns!

Dentsply Sirona has performed better than Capricor Therapeutics in short term. You could have earned much better returns by investing in Dentsply Sirona, about 41.12% more returns!

Capricor Therapeutics Technical analysis of indicators

Price action analysis of Capricor Therapeutics (CAPR) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Capricor Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a SELL signal for Capricor Therapeutics in short term and the sell signal is strong.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Capricor Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up

CCI has generated a buy signal for Capricor Therapeutics in short term but BUY signal is weak.

RSI is generating a BUY signal in short term but buying is losing momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Capricor Therapeutics is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 6.43 and Capricor Therapeutics CAPR stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

People seem to be coming out and selling the Capricor Therapeutics CAPR stock. Volume based technical analysis of Capricor Therapeutics CAPR stock is negative.

Capricor Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock CAPR Capricor Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And CAPR Experts View which covers a lot of information including buying and selling signals

CAPR future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Capricor Therapeutics or View Candle Stick Charts here

Chart Capricor Therapeutics (CAPR)  Technical (Analysis) Reports Capricor Therapeutics [

Videos related to: Capricor Therapeutics (CAPR) Technical (Analysis) Reports Capricor Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Basics How To Trade In FnO Futures Options Stock Market

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Capricor Therapeutics (CAPR)  Technical (Analysis) Reports Capricor Therapeutics [

 

Back to top